HAL (France)open access
Bivalency of natalizumab promotes inhibition of dynamic VLA-4 adhesion beyond affinity gain
0, Cell adhesion Force, Antibody Affinity, 1, 2, Microfludics, Cell migration
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 684872
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.